The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Latest News

APR
01
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2021
MAR
30
The United Laboratories International Holdings Limited, Announces 2020 Annual Results, Profit attributable to Shareholders up by 9.5% to RMB703 Million, Insulin Series Beat Sales Targets
MAR
30
2020 ANNUAL RESULTS ANNOUNCEMENT

2020

Interim Report
PDF

ESG Report 2019

  • Environment
  • Social
  • Governance

Presentation

Investor Information

  • Regulatory Filings
  • Corporate Governance
  • Stock Quotes & Charts
  • FAQs

IR Contact

6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong
tulir@tul.com.hk
Disclaimer | Sitemap

Copyright © 2019 The United Laboratories International Holdings Limited. All rights reserved.